Cytek Biosciences, Inc. Common Stock

CTKBNASDAQUSD
4.09 USD
0.24 (5.54%)AT CLOSE (11:59 AM EDT)
4.12
0.03 (0.61%)
POST MARKET (AS OF 07:09 PM EDT)
Post Market
AS OF 07:09 PM EDT
4.12
0.03 (0.61%)
🔴Market: CLOSED
Open?$4.24
High?$4.45
Low?$4.02
Prev. Close?$4.33
Volume?912.4K
Avg. Volume?948.3K
VWAP?$4.14
Rel. Volume?0.96x
Bid / Ask
Bid?$3.88 × 600
Ask?$4.06 × 900
Spread?$0.18
Midpoint?$3.97
Valuation & Ratios
Market Cap?528.2M
Shares Out?129.1M
Float?115.5M
Float %?90.4%
P/E Ratio?N/A
P/B Ratio?1.61
EPS?-$0.57
Dividend?0.00%
Ex-Dividend?N/A

Cytek Biosciences, Inc. Common Stock (CTKB) is currently trading at $4.09. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest CTKB is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Employees
702
Market Cap
523.0M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
2021-07-23
Address
47215 LAKEVIEW BOULEVARD
FREMONT, CA 94538
Phone: (877) 922-9835
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
80
Momentum?
92
Short Sent.?
74
Piotroski F-Score?3/9Weak
Altman Z-Score?3.32Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?5.94%Elevated
Short Interest?6.9M
Days to Cover?6.0
Free Float115.5M
Avg Daily Volume1.2M
Settlement Date2026-05-15
Financial Health
Current Ratio?4.69Strong
Quick Ratio?4.07Strong
Cash Ratio?0.81Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
84
1.61CHEAP
P/S?
Peers
100
S&P
56
2.59CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-12.8CHEAP
EV/Sales?
Peers
100
S&P
71
2.27CHEAP
Returns & Efficiency
ROE?
S&P
7
-22.6%WEAK
ROA?
S&P
3
-16.5%WEAK
Cash Flow & Enterprise
FCF?$-12700000
Enterprise Value?$462.9M
Fundamentals ratios updated end of day